Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol.
about
Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acidTargeting selectins and selectin ligands in inflammation and cancerDeoxygenated Disaccharide Analogs as Specific Inhibitors of 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor MetastasisGlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolismSuite of activity-based probes for cellulose-degrading enzymesDiscovery of inhibitors of Leishmania β-1,2-mannosyltransferases using a click-chemistry-derived guanosine monophosphate libraryThe Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases.Advances in the biology and chemistry of sialic acids.Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.Glycans in pathogenic bacteria--potential for targeted covalent therapeutics and imaging agents.Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogsMutational and functional analysis of Large in a novel CHO glycosylation mutant.Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivoDiazo groups endure metabolism and enable chemoselectivity in cellulo.Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerationsMetabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis.5-thiomannosides block the biosynthesis of dolichol-linked oligosaccharides and mimic class I congenital disorders of glycosylationMetabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamineCellular metabolism of unnatural sialic acid precursors.Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cellsExtracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.Cell-permeable probe for identification and imaging of sialidasesChemical probing of glycans in cells and organismsGlycan antagonists and inhibitors: a fount for drug discovery.Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cellsChemical approaches to perturb, profile, and perceive glycans.Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesisBase-modified UDP-sugars reduce cell surface levels of P-selectin glycoprotein 1 (PSGL-1) on IL-1β-stimulated human monocytes.Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth.Metabolic glycoengineering: sialic acid and beyondMonitoring dynamic glycosylation in vivo using supersensitive click chemistryUnderstanding glycomechanics using mathematical modeling: a review of current approaches to simulate cellular glycosylation reaction networks.Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.Azido sialic acids can modulate cell-surface interactions.Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys.Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.'Click'-xylosides as initiators of the biosynthesis of glycosaminoglycans: Comparison of mono-xylosides with xylobiosides.
P2860
Q24338142-E135D123-A43B-44CE-9D57-F9B395CFDB48Q24658204-A46E679C-FBD5-4694-A02C-2CA279B43BE8Q27653257-DBF399DF-4392-407E-83D7-077281FAD217Q28218950-4DADAC9B-0B07-4A21-9B2D-F9DC2BCEAEB2Q28710088-34E60848-E8BC-452B-9236-88FA1262F9E3Q28731622-CB1C3364-61D2-4C89-85FB-B32A8913BA67Q30863560-A87B4FE5-A810-4CFD-9760-69CEFCC93CF6Q33519629-E5A880F8-EBC4-4DC1-AFD1-4385AFBD91C0Q33677498-07CA72DF-B5E7-425B-8525-26B660F40D3CQ33725733-5DADA88C-E57A-4A74-A924-AB82D8D0BCACQ34370155-87CD58E2-2148-467F-9D3C-0C7587BC855AQ34573505-299F3414-1C46-4908-B43D-45BE645619AFQ34983110-C7B11835-5EAB-4979-BCDC-008D494D116CQ35033695-63E1A172-69FB-4781-95D8-BB88AB555361Q35213301-BCA82478-F8F9-4E90-89B2-35F14F0033C7Q35669639-91EC6ADD-C9F7-4ADB-AC09-BEA9A5A308D3Q35785590-2F6BD8EA-0CED-4E88-872D-DA76AEE7DFADQ36089893-D7D0BD8B-90BA-4A49-AA1F-57DA01423468Q36208696-806EAED4-E6E3-40DA-A288-AC43954CFB3CQ36217214-6CA40D5D-B5EA-4F7D-B85C-18B5A59A51E2Q36270708-55DE7874-49EF-4816-B3AA-7DA1E7FF3C11Q36420667-1C1E176C-4169-4ECF-B27D-DB5AF17ACEA2Q36488687-4E0D827F-A899-4213-BE37-838CE836651FQ36617100-B435DA74-D215-4858-B882-B76EF243305CQ36811051-1074659E-75A0-4446-AE8E-C9EEDF7F3D05Q37027396-CA3D8F73-9728-4C11-A54E-25E289CEA22AQ37133422-EE7C8C24-CC50-48F6-98BF-B49460E7E891Q37229796-3F7E3B2A-CE85-4DFF-8FFE-FFC4D44BD9A6Q37291115-6946CEFF-1EB8-40DF-A170-A5F510E83035Q37353392-08F5058F-71CA-43A2-AC85-736C75A1BF16Q37378007-48DB68B1-E0E7-4A44-A261-01555477B49EQ37405391-78DF73EC-4ED2-48D1-8CC9-6C31F23F759DQ37714104-0729408E-508D-4732-A431-2F0BF76942A0Q37957027-27ECA867-7BE3-4FFF-9E0C-04B1AFC3E545Q38301000-A39366EE-D68E-4443-92E8-1B46AC7C5B5AQ38333763-527D779C-A1AC-42DE-8FBB-A1297DF3DD53Q38355768-EE58C926-0CD1-447B-8D0B-57EA484422F7Q38452524-176FCF3F-E9BE-4EC9-9245-62014D5715F7Q38715644-0495C088-8D1B-46E5-A4D8-621BCAFB4947Q38734353-7156D6CE-9B8A-483B-BDEC-839574560E59
P2860
Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@ast
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@en
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@nl
type
label
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@ast
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@en
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@nl
prefLabel
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@ast
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@en
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@nl
P2093
P2860
P356
P1476
Disaccharide uptake and primin ...... Ac beta-O-naphthalenemethanol.
@en
P2093
P2860
P304
P356
10.1073/PNAS.92.8.3323
P407
P577
1995-04-01T00:00:00Z